To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Esketamine with Hip Nerve Block Provides Effective Sedation And Analgesia In Elderly THA Patients

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2025

Esketamine with Hip Nerve Block Provides Effective Sedation And Analgesia In Elderly THA Patients

Vol: 307| Issue: 6| Number:126| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

A subanesthetic dose of esketamine combined with hip peripheral nerve block has good sedative and analgesic effects in elderly patients undergoing total hip arthroplasty: A randomized-controlled trial.

Jt Dis Relat Surg . 2023 Sep 16;34(3):548-556.

Contributing Authors:
B Dai Y Huo

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred twenty elderly patients undergoing total hip arthroplasty were randomized to receive a subanesthetic dose of esketamine combined with hip capsule peripheral nerve block (n=40)(Group A), esketamine with lumbar plexus block (n=40)(Group B), or esketamine for general anesthesia (n=40)(Group C). The primary outcomes of interest were onset time of anesthesia, duration of block, postoperativ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue